Related Experiment Video
Updated: Apr 5, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Physostigmine effects on serotonin uptake in human blood platelets
Physostigmine salicylate temporarily lowered mood and decreased serotonin uptake in platelets, suggesting a role for cholinergic mechanisms in depression. This study explored the link between mood, platelet function, and neurotransmitter transport.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Platelet serotonin uptake is a model for central serotonergic activity.
- Cholinergic systems are implicated in mood regulation and depression.
Purpose of the Study:
- To investigate the effect of physostigmine salicylate on platelet serotonin uptake and mood.
- To explore the potential role of cholinergic mechanisms in depression.
Main Methods:
- Double-blind, placebo-controlled crossover study with 18 subjects.
- Measurement of platelet serotonin uptake kinetics (Vmax and Km).
- Assessment of mood using self- and observer-rated depression scores.
Main Results:
- Physostigmine salicylate induced transient mood depression.
- The drug significantly increased platelet counts.
- Physostigmine decreased the maximum velocity (Vmax) of platelet serotonin uptake, but not the affinity constant (Km).
Conclusions:
- Cholinergic stimulation via physostigmine affects platelet serotonin uptake.
- These findings support the hypothesis that cholinergic mechanisms may reduce platelet serotonin uptake in depressed patients.
More Related Videos
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...